Galicia has approved a €15.6 million investment to supply gene therapy for hemophilia B, becoming the first region in Spain to do so. The therapy, Etranacogene...
Gender parity reached 68.8% in 2025, but progress is slowing, with full equality projected 123 years away. Women excel in education but lack leadership roles. Political...
Sugar prices dipped in New York and held steady in London. China remained an active buyer. Drier weather in Brazil accelerated the cane harvest. India and...
Bitcoin dropped sharply after Israel bombed Iran but rebounded by Monday, calming fears of a crash. Ethereum, Solana, and XRP showed mixed reactions, while Solana surged...
The Fourth Turning by Strauss and Howe outlines recurring 85-year historical cycles of societal change, each with four 20-year eras—High, Awakening, Unraveling, and Crisis. The current...
This week, the Dow Jones failed again to reach new highs, closing 6.26% below its December peak. Despite geopolitical tensions boosting gold, the Dow continued its...
DeFi Development Corp. (DFDV), a Nasdaq-listed firm, plans to buy up to $5 billion in Solana (SOL) using a credit line backed by shares. Echoing MicroStrategy's...
A BioSim study highlights biosimilars’ crucial role in reducing Spain’s healthcare spending, projecting €22.27 billion in savings from 2024–2030. Despite rising biologic drug costs, biosimilars ensure...
Bepi Dispenser, Italy’s first bedside medicine robot, raised over €460K via Mamacrowd and launches this autumn. Tested in Habilita clinics, it automates drug delivery to improve...
Banque Centrale Populaire's strong fundamentals, rising revenues, and prudent risk management drive Attijari Global Research to maintain its "Buy" rating. With growing net banking income, improved...